Janus Henderson Group PLC Insmed Inc Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Insmed Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,091,778 shares of INSM stock, worth $155 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,091,778

Previous 2,229,463 6.18%

Holding current value

$155 Million

Previous $60.5 Million 131.71%

% of portfolio

0.08%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $3.03 Million - $9.6 Million	-137,685 Reduced 6.18%	2,091,778 $140 Million
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $21.3 Million - $24.7 Million	826,372 Added 58.9%	2,229,463 $60.5 Million
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $12 Million - $16.2 Million	-511,711 Reduced 26.72%	1,403,091 $43.5 Million
Q3 2023 Nov 14, 2023	SELL	$19.86 - $26.93 $5.57 Million - $7.55 Million	-280,386 Reduced 12.77%	1,914,802 $48.3 Million
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $6.02 Million - $7.72 Million	-365,981 Reduced 14.29%	2,195,188 $46.3 Million
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $7.07 Million - $9.45 Million	-435,083 Reduced 14.52%	2,561,169 $43.7 Million
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $7.22 Million - $9.84 Million	-425,074 Reduced 12.42%	2,996,252 $59.9 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $74.7 Million - $101 Million	-3,579,011 Reduced 51.13%	3,421,326 $73.7 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $11.6 Million - $17.4 Million	-677,929 Reduced 8.83%	7,000,337 $138 Million
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $4.15 Million - $5.72 Million	-203,292 Reduced 2.58%	7,678,266 $180 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $2.75 Million - $3.56 Million	-106,341 Reduced 1.33%	7,881,558 $215 Million
Q3 2021 Nov 16, 2021	BUY	$22.46 - $29.47 $806,269 - $1.06 Million	35,898 Added 0.45%	7,987,899 $220 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $41.9 Million - $62.4 Million	1,733,425 Added 27.87%	7,952,001 $226 Million
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $12.8 Million - $17.6 Million	396,163 Added 6.8%	6,218,576 $212 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $10.9 Million - $14.1 Million	-346,754 Reduced 5.62%	5,822,413 $194 Million
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $79.9 Million - $106 Million	-3,073,205 Reduced 33.25%	6,169,167 $198 Million
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $5.8 Million - $12.1 Million	411,016 Added 4.65%	9,242,372 $255 Million
Q1 2020 May 14, 2020	SELL	$13.63 - $33.98 $38.7 Million - $96.4 Million	-2,835,922 Reduced 24.31%	8,831,356 $142 Million
Q4 2019 Feb 18, 2020	SELL	$16.12 - $24.98 $7.31 Million - $11.3 Million	-453,301 Reduced 3.74%	11,667,278 $279 Million
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $7.07 Million - $11.8 Million	456,389 Added 3.91%	12,120,579 $214 Million
Q2 2019 Jul 31, 2019	BUY	$23.0 - $32.19 $8.32 Million - $11.6 Million	361,756 Added 3.2%	11,664,190 $299 Million
Q1 2019 Apr 30, 2019	SELL	$13.91 - $31.15 $1.66 Million - $3.71 Million	-119,027 Reduced 1.04%	11,302,434 $329 Million
Q4 2018 Feb 06, 2019	BUY	$11.6 - $18.7 $24.5 Million - $39.6 Million	2,116,129 Added 22.74%	11,421,461 $150 Million
Q3 2018 Nov 09, 2018	BUY	$18.95 - $28.08 $35.1 Million - $52 Million	1,850,394 Added 24.82%	9,305,332 $188 Million
Q2 2018 Aug 10, 2018	BUY	$20.0 - $29.72 $24.2 Million - $35.9 Million	1,208,596 Added 19.35%	7,454,938 $176 Million
Q1 2018 May 14, 2018	BUY	$21.69 - $32.99 $6.14 Million - $9.34 Million	283,136 Added 4.75%	6,246,342 $141 Million
Q4 2017 Feb 09, 2018	BUY	$26.43 - $31.78 $52.9 Million - $63.6 Million	2,002,458 Added 50.56%	5,963,206 $186 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $26.8 Million - $72.2 Million	2,312,045 Added 140.23%	3,960,748 $0
Q2 2017 Aug 17, 2017	BUY	N/A	1,648,703	1,648,703 $28.3 Million

Others Institutions Holding INSM

# of Institutions

447

Shares Held

170M

Call Options Held

5.79M

Put Options Held

5.18M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Insmed Inc Transaction History